The present study has focused exclusively on the effects of four gene knockdown on drug sensitivity in colorectal cancer cells, without delving into the molecular mechanisms through which three of these key genes – BAMBI, MAPK8IP2, and BMP7 – regulate oxaliplatin sensitivity. This evidence concerns the gene MAPK8IP2 and colorectal cancer.